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April 14, 2015
In this article we report on the work carried out within the framework
of a summer project, part–funded by an IMA small grant, in which an un-
dergraduate student (the second author of this manuscript) developed and
implemented methodology for disease classification from gene expression
microarray data. While the original motivation for this study was the de-
velopment of a correlation threshold for gene filtering, a general outcome of
this research was that, using very simple statistical techniques (essentially
at undergraduate level) but solid state–of–the–art validation routines, good
classification accuracies can be obtained using relatively small–sized gene
signatures. We applied the techniques on expression data for breast cancer
tumour subtype classification, as well as for prediction of the presence or
absence of Irritable Bowel Syndrome (IBS).
Introduction
Since the groundbreaking work by Golub et al. (1999), the problem of dis-
ease classification through microarray gene expression data has attracted a
∗corresponding author, jochen.einbeck@durham.ac.uk, 0191 3343125
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2tremendous amount of attention in the medical, bioinformatical and statis-
tical research literature, with tens of thousands of published articles over
the last 15 years. A typical dataset consists of n subjects, each of which has
a pre-regularised measure of mRNA expression for each of the p parameters
or genes. Typically, n is in the tens or hundreds, and p in the thousands
or tens of thousands, but in any case one will have n << p, rendering
standard statistical techniques inapplicable. The key task in microarray–
based disease classification is the selection of a few significant genes for
which the expression values are particularly informative for discriminating
the different categories.
As an example, consider the gene expression values of two particular
genes from a microarray dataset collected from patients with lymph-node-
negative breast cancer (Figure 0.1), which is introduced in full later on. The
categories to be discriminated are estrogen–receptor positive (ER+) and
negative (ER-). It is obvious that for the left–hand gene, the ER- category
tends to correspond to high and the ER+ category to low expression values,
rendering this gene very informative for this problem. In contrast, for the
right–hand gene the expression values are not separating the groups well
and hence do not seem to be a useful indicator for the estrogen–receptor
category.
Methodologically, what is needed from this point is a formal procedure
for identifying (‘filtering’) significant genes (or groups of genes), as well as
a classifier to carry out the actual classification task. It is also possible to
carry out both steps at once, using sufficiently strong regularization in the
classification step. Driven by a research environment in which “many jour-
nals require methodological innovation” (Boulesteix, 2006) as publication
criterion, these statistical techniques have become more and more advanced
over recent years. Though these advances have undoubtedly been valuable
(with impact far beyond the field of microarray analysis), the complexity of
these approaches has left these with a black–box flavour, which may turn
out to be detrimental to the acceptance of such methodology in clinical
practice.
In this summer project we took a back–to–the–root approach, effectively
only using
(a) for the gene selection, a 2–sample–t–test which captures effects of the
type depicted in Figure 0.1; as well as
(b) a correlation threshold to eliminate highly correlated genes (this was
the original motivation for this work);
(c) for the classification step, diagonal linear discriminant analysis.
We paid careful attention to the question of validation, and we achieved
good (or very good) prediction accuracy rates for all considered scenarios.
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Figure 0.1: Comparing the plots of the expression values of genes which
are potentially informative (left) or uninformative (right) for the estrogen-
receptor level.
We considered two data sets, where the first one concerns the classification
of certain breast cancer tumour subtypes, while the second one concerns
the prediction of presence or absence of Irritable Bowel Syndrome.
Feature selection
Many methods of gene selection involve ranking the genes with regard to
a certain test statistic. A higher test statistic value corresponds to a gene
being seen as more important for differentiating between two or more dis-
tinct groups. A simple choice for such a test statistic is the two–sample–
t–test, which compares the difference in mean expression values, standard-
ized by a pooled variance estimate, to an appropriate quantile from the t–
distribution. Testing and ranking genes individually in this manner ignores
the fact that some groups of genes may contribute very similar information,
and so inflates the number of required genes. This problem can be dealt
with in two different ways. Firstly, rather than carrying out univariate
tests marginally on every gene, one can apply multivariate variable selec-
tion approaches which try to identify combinations of genes which jointly
optimize prediction accuracy — taking the standpoint that “the subset of
the variables with the best univariate discrimination power is not necessar-
4ily the best subset of variables” (Boulesteix et al, 2008). Techniques used
in this field include Hotelling’s two-sample T 2–statistic for groups of mul-
tiple variables as well as the top scoring pair or subset approaches (e.g.
Yang and Naiman, 2014). However, these methods are quite complex and
computationally intensive, and the publications dealing with them often of
rather theoretical nature. Therefore, in this work, we went with the simpler
concept of removing ‘redundant’ genes whose expression shows a high corre-
lation with genes higher up in the list. The incorporation of this correlation
threshold into the feature selection process makes the ‘wrong’ assumption of
independent genes more reasonable. Our correlation threshold can be seen
as a simplified version of that one suggested by Ja¨ger et al. (2003), who
excluded genes with high correlation to previously included genes, rather
than genes higher up in the list.
Ordering the genes with regard to decreasing test statistic gives an order
of importance. That is, each gene is considered in rank order but is selected
only if it does not have a correlation higher than a certain threshold, b, with
a gene of higher test statistic (or equivalently, lower p–value). The top k
remaining genes can be chosen for use in classification.
The remaining question of how many genes to select is of high impor-
tance for diagnostic biomakers. This depends on the particular application,
but usually a low budget of genes is preferential or necessary because of
computational efficiency and the financial cost of processing a single gene
expression. In practice a trade–off is required between the additional cost of
including extra genes and the expected benefit for the increase in accuracy.
Classification
Once a list of genes has been selected, it is necessary to have a classifier
which can take the expression values for these particular genes as inputs,
and return a response indicating (say) the presence or absence of a disease
as output. The classification problem is in this context equivalent to a pre-
diction problem: Classification is the prediction of the diagnostic category
of a tissue sample from its gene expression values given the availability of
similar data from tissues in identified categories (Yeung and Bumgarner,
2003). There do exist many classifiers, including several discriminant tech-
niques, logistic regression, nearest-neighbour classifiers, classification trees,
random forests and support vector machines. In this article we will use
a very simple classifier, Diagonal Linear Discriminant Analysis (DLDA),
which postulates a multivariate Gaussian distribution with equal and diag-
onal covariance matrices for each classification group, and then places the
5decision boundary such that, on this boundary, the data are just equally
likely to belong to each of the two groups. DLDA is generally quicker and
more efficient than Linear Discriminant Analysis since the latter requires
the estimation of full covariance matrices which involves many more param-
eters. Our experience has shown that ‘full’ LDA, or even extensions such as
quadratic discriminant analysis, do not improve the classification accuracy
but rather add variability to the classification problem.
DLDA is particularly attractive in conjunction with a correlation thresh-
old. From a mathematical point of view, the assumption of diagonal covari-
ance matrices is incorrect as it would imply that expression values for all
genes are independent of each other. By selecting genes that are less highly
correlated with each other, we can reduce this invalidity and the effect that
it has, as much as possible. Thus we have a further motive for removing
highly correlated genes.
Validation
Once a classifier has been chosen, it is necessary to check its validity to
see how accurately it predicts future subjects. To avoid overfitting, it is
essential that the model is validated for other individuals than used to
build the classifier. Furthermore, as highlighted by Boulesteix et al (2008),
it is important that this validation procedure includes the gene filtering
step, not only the classification step. One suitable method for this purpose
is the cross-validation method, in which we split the data into a training
set and a test set. The training set is used to select significant genes and
build a classifier. For the test set one works out the proportion of the
responses of data items which are correctly predicted by the classifier. This
process is repeated many times so that lots of different combinations of
training and test sets are considered, and the results are averaged to obtain
an average accuracy rate. Throughout this article a training set comprising
of 75% of the data is used for feature selection and classification, whilst
the remaining 25% are used to test the classifier to obtain a proportion
of correctly predicted cases. Our experiments repeated this procedure for
3000 different randomly sampled training and test sets and then averaged
the resulting accuracies obtained over all of them.
6Breast Cancer
Firstly we consider a microarray data set obtained from n = 286 lymph-
node-negative primary breast cancer patients (Wang et al. 2005), with
expression values available for p = 17816 genes. We consider two possible
groupings in the context of this data:
• GROUP: non–aggressive (A) vs aggressive (B) cancers;
• ER: estrogen–receptor positive (ER+) vs. negative (ER-).
We begin our analysis with the inclusion of k = 5 genes and then in-
crease this number in step sizes of 5, each time allowing for correlation
thresholds ranging from b = 0.6 to b = 1.0. The average cross–validated
accuracies over 3000 runs are shown in Figure 0.2, for the GROUP (top)
and ER (middle) classification problems, respectively. We can see that, for
both classification problems for this dataset, the classification accuracies
start to level off from about n = 35 genes on, and settle at prediction accu-
racies slightly above 62% and 89%, respectively. Lowering the correlation
threshold below 1 does not have a tremendous impact, though it is clear
that it leads to a general improvement in accuracy for the GROUP variable,
which however does not turn out to be significant after rigorous statistical
testing. For the ER variable, the correlation threshold enables an increase
of almost one accuracy point for a small number (≤ 15) of selected genes,
which is indeed statistically significant as can be shown through Analysis
of Variance. Informally, this is clear by considering the standard errors of
the accuracies to the right hand side of Figure 0.2: These are of magni-
tude 3.5, so the standard errors of the mean accuracies are of magnitude
3.5/
√
3000 ≈ 0.06, which is much smaller than the distance between the
green and the black curve, for instance. The particularly poor performance
for b = 0.6 and higher number of genes should be noted — using a very low
correlation threshold can lead to the inclusion of noisy genes, which con-
tribute little information to the classification problem. Our accuracy rates
of close to 90% for the ER classification is in line with the rates obtained
in other studies (Roepman et al, 2009). We are not able to compare our
results with Wang et al (2005), who used a larger gene signature of size 76
to solve a different problem.
Irritable Bowel Syndrome
Irritable Bowel Syndrome, IBS, is a prevalent disorder affecting between
10% and 20% of people in the Western world (Aerssens et al., 2008). It is
characterised by recurrent abdominal pain and an increased frequency to
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Figure 0.2: Cross–validated mean accuracy rates (left) and associated stan-
dard errors (right) for Breast Cancer data (top, middle) and Irritable Bowel
Syndrome data (bottom).
8need to empty the bowels. The data are given as a pre–regularised set of
gene expression readings for 21212 genes from cells for each of a cohort of
34 IBS patients and 24 healthy controls.
Means and standard errors of accuracies for 3000 cross-validated runs of
filtering and classification are shown in Figure 0.2 (bottom). Unlike for the
previous data set, the mean accuracy curves take now clearly identifiable
maxima when 15–20 genes are selected. The correlation threshold does
appear to lower the accuracies in this example, though it should be noted
that it still has the positive effect of shifting the maxima towards lower
numbers of genes. The cross–validated accuracies of approximately 70%
are comparable to those found in Aerssens et al (2008) using a complex
combination of techniques.
Conclusion
For the prediction of absence or presence of Irritable Bowel Syndrome, as
well as for breast cancer subtype classification, we have used a simple trilogy
of basic statistical methods (t–test, correlation threshold, DLDA) to achieve
accuracy rates which appear comparable to those provided in the literature
using more complex methods.
A particular focus of this work has been the investigation of the cor-
relation threshold. Yeung and Bumgarner (2003) considered a similar no-
tion of a correlation threshold in connection with a shrinkage threshold for
removing genes to increase the feature stability. Sensible choices for the
correlation threshold are 0.7 ≤ b ≤ 1. We found that threshold values b < 1
are particularly beneficial if the target number of genes is small, say 5-15,
in the sense that it either increases the accuracy, or shifts the accuracy
maximum to the left (see the left column of Figure 0.2). Both the ‘optimal’
choice of the threshold and the number of features for a particular mi-
croarray dataset is specific to the dataset, and could be selected through an
inner cross–validation loop within a nested–loop cross–validation procedure
(Go¨hlmann & Talloen, 2009).
In conclusion, this article has shown that, at least for the examples under
study, very good classification rates can be achieved using simple statistical
methods and relatively small–sized gene signatures. The accuracy curves
presented in this article appear smoother compared to those found in the
literature. The application of a correlation threshold does, in some cases,
lead to an improvement in accuracy, but even in situations where it doesn’t,
it has other conceptual advantages which may still justify its use. The
methods can in principle be extended to classification problems involving
9more than two groups though we did not find the correlation threshold to
be beneficial in this case.
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